Tertiary Lymphoid Structures Related Genes Predicting Prognosis in Clear Cell Renal Cell Carcinoma: a Retrospective Cohort Study
NCT06883565 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 232
Last updated 2025-03-19
Summary
The purpose of this research was to uncover the prognostic significance of tertiary lymphoid structures related genes from ccRCC patients with respect to clinical characteristics and outcomes. This offers a novel perspective on selecting populations for prostate cancer immunotherapy in future scenarios.
Conditions
- Renal Cell Carcinoma (RCC)
Sponsors & Collaborators
-
Ding-Wei Ye
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-06-01
- Primary Completion
- 2025-01-31
- Completion
- 2025-01-31
Countries
- China
Study Locations
More Related Trials
-
Glycosaminoglycan Scores as Monitoring Biomarkers in Confined Renal Cell Carcinoma
NCT02732652 ·Status: COMPLETED
-
Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer
NCT00806650 ·Status: COMPLETED
-
Studying Biomarkers in Samples From Younger Patients With Kidney Cancer
NCT01642095 ·Status: WITHDRAWN
-
Study of Kidney Tumors in Younger Patients
NCT00898365 ·Status: COMPLETED
-
Studying Tumor Tissue Samples From Patients Who Have Undergone Surgery for Localized Kidney Cancer
NCT00908739 ·Status: WITHDRAWN
-
microRNA Expression in Renal Cell Carcinoma
NCT00743054 ·Status: COMPLETED
-
Biomarkers of Angiogenesis for Response to Therapeutic Combination in Advanced or Metastatic Kidney Cancer
NCT05285579 ·Status: UNKNOWN
-
Meta-analysis of the Prognostic Value of Lymphocyte to Monocyte Ratio (LMR) in Non-metastatic Renal Cell Carcinoma.
NCT04213664 ·Status: UNKNOWN
-
Evaluation of HPGD and SCLO2A1 Expression in Clear Cell Renal Cell Carcinoma Patients
NCT06778538 ·Status: COMPLETED
-
Clinical Relevance of NGS Analysis for High-purity CTC From Cancer Patients With Disruptive Gene Mutation(s)
NCT03002350 ·Status: UNKNOWN
-
Gastric Cancer Early Detection by Multi-dimensional Analysis of cfDNA
NCT05668910 ·Status: UNKNOWN
-
Gene Expression in Normal Tissue and Tumor Tissue From Patients Who Have Undergone Surgery For Kidney Cancer
NCT00899860 ·Status: TERMINATED
-
Biomarker Study in Samples From Patients With Malignant Rhabdoid Tumor of the Kidney or Atypical Teratoid Rhabdoid Tumor
NCT01453465 ·Status: WITHDRAWN
-
Genomics and Prognosis in GI Cancers
NCT05767697 ·Status: RECRUITING
-
Prospectively Predict the Immunotherapy Response of Gastric Cancer Based on Circulating Exosomal LncRNA-GC1 Biopsy
NCT05334849 ·Status: COMPLETED
-
Circulating Tumor DNA to Monitor the Efficacy of Total Neoadjuvant Therapy for Rectal Cancer
NCT05356585 ·Status: WITHDRAWN
-
Assessment of Early Detection and Prognosis Based on cfDNA Methylation in Multiple Myeloma
NCT05693012 ·Status: UNKNOWN
-
Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma
NCT04263935 ·Status: RECRUITING
-
Description of Clinical Anatomical Features and Long Term Follow-up for Patients With ALK Rearrangements
NCT02727335 ·Status: COMPLETED
-
Predictive Value of a SNP Signature and Liquid Biopsy in Natural Killer T-cell Lymphoma
NCT04423536 ·Status: UNKNOWN
-
Different Genetic Features Associated With Hepatic Carcinogenesis
NCT01247506 ·Status: UNKNOWN
-
Molecular Profiling in Prostate Cancer
NCT04983628 ·Status: UNKNOWN
-
A Novel Serological Risk Model for Early Non-invasive Diagnosis of Cholangiocarcinoma
NCT06658587 ·Status: NOT_YET_RECRUITING
-
The Detection of Circulating Tumor Cells (CTCs) in Patients With Renal Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment
NCT02450448 ·Status: COMPLETED
-
Taiwan Cancer Moonshot Project
NCT05248763 ·Status: RECRUITING